Psychiatric safety associated with hormone replacement therapy for menopausal symptoms: a real-world study of the FDA adverse event reporting system
It is necessary to conduct personalized risk stratification in HRT management, prioritizing age, administration route, and regimen type. While, further clinical investigations are needed to validate these findings and refine HRT safety strategies.
Authors
- Yi Ren (ORCID: https://orcid.org/0000-0003-1560-5531)
- Chunli Fu (ORCID: https://orcid.org/0000-0003-4378-0863)
- Lei Li (ORCID: https://orcid.org/0000-0002-9180-8552)
- Nan Chen (ORCID: https://orcid.org/0000-0003-4257-7265)
Institutions
- Shenzhen University Health Science Center (CN)
- Qilu Hospital of Shandong University (CN)
- Shenzhen Second People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-06-27
- DOI
- https://doi.org/10.3389/fpsyt.2025.1614087
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00